SLNO
Soleno Therapeutics, Inc. Common Stock
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Best Electromedical Stocks 2026 →
Soleno Therapeutics (SLNO) Stock: Buy, Sell, or Hold?
$53.01
+0.02 (+0.04%)
â˛
5d:
+0.11%
30d:
+0.84%
90d:
+42.35%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: May 06, 2026
0d
Protect SLNO Gains
Updated May 15, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (63%)
Quality Score
48/100
Position
FAIR
Forward P/E & Valuation
8.4x
FAIR
vs 8.9x historical avg
Wall Street Target
$53.00
Consensus price target
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$52.84 / $53.01
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: SLNO is fairly priced but lacks strong directional signals. At -1.8% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Get Alerted When SLNO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$108.93
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$67.64
21.6% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 8.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SLNO is currently trading at $53.01, which is considered fair based on recent price action. The stock's valuation (Forward PE: 8.4) is in line with its historical norms (8.9). Remarkably, the market is currently pricing in an annual earnings decline of 1.8% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SLNO is in a uptrend. The price is currently testing key support at $52.84. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SLNO is in a uptrend. The price is currently testing key support at $52.84. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
48/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
62.9%
Trading Range & Key Levels
Support Level
$52.84
Resistance Level
$53.01
Current Trend
Uptrend
Technical data as of
May 15, 2026
Protect Your Profits
SLNO is technically overbought (RSI 78). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanQuantitative Signal Breakdown
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- NEUTRAL: Near Wall St target ($53.00)
- WARNING: Composite score 48/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
8.43
Wall Street Target
$53.00
Profit Margin
33.7%
Valuation Discount vs History
-1.8% cheaper
PE vs Historical
8.4 vs 8.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.8%
(market-implied from PE analysis)
1-Year Target
$52.06
(-2%)
2-Year Target
$51.12
(-4%)
3-Year Target
$50.20
(-5%)
3-Yr Target (if PE normalizes)
(PE: 8â9)
$52.97
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.1, Growth: 59.2%)
$468.15
(+783%)
Base:
(SPY PE: 8.4, Growth: 59.2%)
$178.91
(+238%)
Bear:
(PE: 7.2, Growth: 59.2%)
$152.07
(+187%)
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 8.4 to 8.9
Stabilization Target:
$55.94
(+5.5%)
PE Expansion Potential:
+5.5%
Share SLNO Analysis
Share this live SLNO analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (SLNO)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Apr 8, 2026
Daily AI digest
AI Retail Discussion Summary:
Neurocrine Biosciences ($SLNO) has acquired Soleno Therapeutics, adding the FDA approved therapy Vykat XR for Prader Willi syndrome to its portfolio. This expansion into rare diseases and endocrinology is expected to diversify revenue streams and strengthen commercial reach.
Key Retail Themes:
company expansion into rare diseases
addition of FDA approved therapy to product line
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 9:18 AM ET
Data refreshes hourly during market hours. Next update: 10:18 AM
Data refreshes hourly during market hours. Next update: 10:18 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SLNO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$107 | 62 BUY |
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$194 | 41 HOLD |
|
MDGL
Madrigal PharmaceuticalsâĻ |
STRONG BUY
19 analysts |
$689 | 55 HOLD |
|
RZLT
Rezolute Inc |
STRONG BUY
11 analysts |
$10 | 72 BUY |
|
IMNM
Immunome Inc |
STRONG BUY
17 analysts |
$35 | 47 HOLD |
Advanced SLNO Option Strategies
Professional options setups generated by AI based on today's SLNO price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive SLNO Research Pages
